AzTrials
AzTrials

The Upper Esophageal Sphincter Contraction StrengthNCT05999786

ERAS Swallowing Rehabilitation in Elder Patients

A study testing early rehabiliation swallowing program and not receiving early rehabilitation swallowing program in people with The Upper Esophageal Sphincter Contraction Strength, run by National Taiwan University Hospital.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The investigators studied that swallowing function of patients receiving the Early Recovery Accelerated Swallowing (ERAS-W program) training will recover fast than that of patients in the control group. The ERAS program training will be initiated before surgery and continue to after surgery. Read more about this study

Who is it for?
Ages 20 to 80 years
What is being tested?
early rehabiliation swallowing program and not receiving early rehabilitation swallowing program
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
50 participants
Where
No sites listed yet
Study dates
10 Aug 2023to 31 Dec 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • elective surgery
  • general anesthesia with endotracheal intubation

Who cannot join

  • major organ dysfunction, ex: chronic kidney disease, hear failure
  • bleeding tendency

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Chih-Min Liu, MD contact

_886-972652224

lewisliu@ntuh.gov.tw

About this study

Official title: Effectivity of Early Recovery Accelerated Swallowing Program on Promoting Swallowing Recovery in Older Patients With High Risk of Oral Frailty Requiring Endotracheal Intubation During General Anesthesia: a Pilot Randomized Control Trial

The investigators studied that swallowing function of patients receiving the Early Recovery Accelerated Swallowing (ERAS-W program) training will recover fast than that of patients in the control group. The ERAS program training will be initiated before surgery and continue to after surgery.

Read the detailed description

The older patients (≥65 years old) with OFI-8≥4 undergoing elective orthopedic surgery requiring tracheal intubation will be recruited. Patients will be randomized into an intervention and a control group. Patients in the intervention groups will received the ERAS-W program, while those in the control group will receive the swallowing education video.

Being tested
early rehabiliation swallowing program, not receiving early rehabilitation swallowing program

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • early rehabiliation swallowing programBehavioural

    not receiving early rehabilitation swallowing program from before and after surgery

  • not receiving early rehabilitation swallowing programBehavioural

    the Taiwan Dysphagia Society's publicly shared swallowing exercises for dysphagia, which is from before and after surgery

Study groups in NCT05999786
Study groupRoleWhat they receive
patients receiving early rehabiliation swallowing programActive comparatorthe early rehabilitation program beginning from before to after surgery
Receives: Behavioral: early rehabiliation swallowing program
patients not receiving early rehabilitation swallowing programPlacebo comparatorthe Taiwan Dysphagia Society's publicly shared swallowing exercises for dysphagia, which is started from before to after surgery
Receives: Behavioral: not receiving early rehabilitation swallowing program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. UES pressure, mmHg

    Measured: about six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2023
  2. Study start10 Aug 2023 (estimated)
  3. Primary completion31 Dec 2028 (estimated)
  4. Study completion31 Dec 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients receive early recovery of swallowing rehabiliation before surgery and continued to after surgery
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05999786
Sponsor's protocol ID
202303005RIND
Status last verified
Aug 2023
First submitted
6 Aug 2023
Last updated
21 Aug 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: due to ethical problem

Questions about this trial

What is this clinical trial studying?

A study testing early rehabiliation swallowing program and not receiving early rehabilitation swallowing program in people with The Upper Esophageal Sphincter Contraction Strength, run by National Taiwan University Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 21 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Chih-Min Liu, MD (_886-972652224, lewisliu@ntuh.gov.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

UES pressure, mmHg (time frame: about six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in